Microsoft vs Revvity Inc — how do they compare? Microsoft trades at $499.7 (market cap $3.74T), while Revvity Inc trades at $115.76 (market cap $12.91B). The key difference: Microsoft is far larger — about 289.7× Revvity Inc's market cap, and Microsoft pays the higher dividend (0.72%). Which is the better fit depends on your goals.
| MSFT | RVTY | |
|---|---|---|
Market Cap | $3.74T | $12.91B |
Volume | 36,654,621 | — |
Sector | Technology | Technology |
52-Week High | $542.07 | $117.75 |
52-Week Low | $352.83 | $82.26 |
Enterprise Value | $3.72T | $15.23B |
Dividend Yield | 0.72% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
Microsoft (MSFT) trades at $506.06, up 1.21% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $281.72B revenue, 40.31% net margin, and consistent earnings beats. Analyst consensus remains overwhelmingly positive with 80.49% buy ratings and $552.73 price target, representing 9.2% upside potential. Recent news highlights Microsoft's AI leadership and cloud computing strength.
Microsoft presents a compelling investment case with strong financial performance and AI-driven growth prospects. Key opportunities include Azure cloud expansion and Copilot adoption, while risks involve increased capital expenditures and competitive pressures. The stock's current valuation at 28.19 P/E appears reasonable given growth trajectory, though investors should monitor execution on AI investments and macroeconomic conditions affecting tech spending.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →